Investing in New Frontiers
Orum is a global biopharmaceutical company bringing life-changing therapies to patients by combining the power of the emerging field of protein degraders with the precision of antibodies.
Our company exists to cure cancer patients and beyond, through innovative research and development of therapeutics and technologies. We aim to succeed by maintaining our leadership in Degrader Antibody Conjugate (DAC) technology, fostering an engaged culture, and cultivating high talent density. Our collaborative, self-driven approach, coupled with our commitment to openness and truth, drives our mission to transform patients' lives.
Events
View all upcoming and past events